Top 2026 Life Sciences Content #10: AI for Clinical Trials: A New EU Procurement Paradigm

Clinical research trials are notably expensive, as are clinical trial translation, and other regulatory translation and life sciences content services. Global procurement and clinical outsourcing professionals need AI-powered translation and content for life sciences that cuts:

• Costs
• Operational timelines
• Administrative oversight of clinical trial costs

Read this blog to discover expert approaches for EU clinical trial applications under the centralized Clinical Trials Information System.

Top 2026 Life Sciences Content #9: AI and Clinical Trials: Can AI author plain language summaries of clinical trial results?

Plain language summaries are essential clinical research communication tools. Plain language writing offers clinical trial volunteers a trial results summary in non-scientific, easily accessible language and builds trust outside the medical community. Lionbridge offers AI-powered, expert-led solutions for plain language communication, including authoring EU CTR-compliant clinical summaries for laypeople.

Top 2026 Life Sciences Content #8: AI-Powered Readability Testing for Life Sciences: How to improve plain language communication and patient engagement

Today's increased focus on patient engagement and transparency necessitates AI-powered solutions that improve content readability for laypeople. Learn more about readability testing and health literacy as keys to better patient outcomes and engagement. Then, discover our AI-powered readability testing technology, Lionbridge Aurora Plain Language™, and find out how it can help your team better connect with people outside the medical community.

Top 2026 Life Sciences Content #7: Life Sciences Translation Services for Venture Investments

Venture investment activities such as Mergers and Acquisitions (M&A), Licensing Partnerships, and IPO activities drive innovation, foster growth, and maintain a competitive edge in the biopharmaceutical and MedTech industries. MedTech and the biopharma industry will face growth gaps due to patent expirations and the rise of China’s emerging biotech industry. Find out how Lionbridge can help via our expert-led AI translation tools for life sciences and venture investments.

Top 2026 Life Sciences Content #6: Whitepaper: Successfully Authoring and Translating Plain Language Summaries

Read this whitepaper from our life sciences translation services team about the challenges of plain language communication. You'll find recommendations for converting scientific research results into text that adheres to plain language principles and resonates with readers outside the medical community. This whitepaper also delves into the skills needed for turning scientific summaries into plain language writing, then translating them into local languages. Learn how a centralized, end-to-end Lionbridge language process helps maintain consistency and quality.

Top 2026 Life Sciences Content #5: Clinical Trial Translation Whitepaper: The Challenges and Opportunities of the EU's New Centralized Clinical Trial Approach

The EU Clinical Trial Regulation (CTR) has profoundly changed the application, approval, execution, and reporting of clinical trials and clinical trial translation in the EU. Joint review procedures were established across the 27 EU Member States, which impact standard timelines and how trial sponsors, regulators, and the clinical supplier landscape interact. Adapting regulatory translation services for clinical trial documentation is now critical for EU clinical trials. Read our whitepaper for guidance on clinical trial translation and other language-related workflows under the EU CTR.

Top 2026 Life Sciences Content #4: Croma-Pharma Case Study: SSCP Readability Validation with AI-powered Readability Testing

The Medical Device Coordination Group (MDCG) recommends readability testing for patients or laypersons when creating Summaries of Safety and Clinical Performance (SSCP). SSCP readability assessment can be done via user consultation or other manufacturer-determined methods. Read our case study about helping Croma-Pharma improve the readability of its SSCP laypersons’ part. Learn how Lionbridge helped Croma-Pharma improve its SSCPs via readability testing and our innovative AI-powered readability assessment tools.

Top 2026 Life Sciences Content #3: ISOQOL 2025 Conference Recap

Lionbridge’s COA solutions team proudly attended and presented two posters at the 2025 ISOQOL Conference. Our COA services focus heavily on AI in COA workflows, particularly in linguistic validation and eCOA migration. We presented two posters:

• The Future of Linguistic Validation is Now: Enhancing Reconciliation Process Compliance with GenAI
• GenAI in Action: A Study on the Efficacy of AI Comparative Review Output

Read our blog to learn more about our posters and conference takeaways.

Top 2026 Life Sciences Content #2: Boston Scientific Case Study: Medical Device Documentation Translation for Improved Outcomes

Learn how Lionbridge partnered with Boston Scientific, providing medical device documentation translation services to help them centralize language translations for their SSCPs and their Instructions for Use (IFUs). Through our medical device translation services, we assisted with content optimization across Labeling and Regulatory Affairs in 17 translation projects and 24 languages. Read about the benefits of centralizing language assets for a device across interdependent technical device documentation, even when different functions own the documents. Our approach also helped Boston Scientific boost language outcomes throughout the entire device life cycle.

Top 2026 Life Sciences Content #1: eBook: EU MDR and IVDR Language Guidance

Have questions about EU MDR and IVDR language requirements? These stringent regulations, with full life cycle emphasis, influence how medical device manufacturers approach life sciences translation and localization. Read our eBook about planning regulatory translations and medical device translation projects. The eBook comprehensively reviews all MDR and IVDR Articles related to language outcomes. It also offers guidance on using AI for life cycle language strategy.

Get in touch

Ready to develop and implement your 2026 language and life sciences content strategies? Interested in learning how AI can help you cut life sciences language services costs and turnaround times? Let’s get in touch to discuss.